Congressional Bills

H.R. 6 (EAH)

948 sections

Preamble115 HR 6 EAH: SUPPORT for Patients and Communities Act
PreambleIOpioid Crisis Response Act1001.DefinitionsIn this title—(1)the terms Indian Tribe and tribal organization have the m...
PreambleTo provide for opioid use disorder prevention, recovery, and treatment, and for other purposes.
PreambleTo provide for opioid use disorder prevention, recovery, and treatment, and for other purposes.
PreambleTo provide for opioid use disorder prevention, recovery, and treatment, and for other purposes.
PreambleTo provide for opioid use disorder prevention, recovery, and treatment, and for other purposes.
Sec. 1Short title; table of contents
Sec. 1Short title; table of contents
Sec. 1Short title; table of contents
Sec. 1Short title; table of contents
Sec. 1Short title; table of contents
Sec. 1Short title; table of contents
Sec. 101At-risk youth Medicaid protection
Sec. 102Health Insurance for Former Foster Youth
Sec. 103Demonstration project to increase substance use provider capacity under the Medicaid program
Sec. 104Drug management program for at-risk beneficiaries
Sec. 105Medicaid drug review and utilization
Sec. 106Guidance to improve care for infants with neonatal abstinence syndrome and their mothers; GAO study on gaps in Medicaid coverage for pregnant and postpartum women with substance use disorder
Sec. 107Medicaid health homes for opioid-use-disorder Medicaid enrollees
Sec. 201Authority not to apply certain Medicare telehealth requirements in the case of certain treatment of a substance use disorder or co-occurring mental health disorder
Sec. 202Encouraging the use of non-opioid analgesics for the management of post-surgical pain
Sec. 203Requiring a review of current opioid prescriptions for chronic pain and screening for opioid use disorder to be included in the Welcome to Medicare initial preventive physical examination
Sec. 204Modification of payment for certain outpatient surgical services
Sec. 205Requiring e-prescribing for coverage of covered part D controlled substances
Sec. 206Requiring prescription drug plan sponsors under Medicare to establish drug management programs for at-risk beneficiaries
Sec. 207Medicare coverage of certain services furnished by opioid treatment programs
Sec. 301Clarifying FDA regulation of non-addictive pain and addiction therapies
Sec. 302Surveillance and Testing of Opioids to Prevent Fentanyl Deaths
Sec. 303Allowing for more flexibility with respect to medication-assisted treatment for opioid use disorders
Sec. 401Promoting value in Medicaid managed care
Sec. 402Extending period of application of Medicare secondary payer rules for individuals with end stage renal disease
Sec. 403Requiring reporting by group health plans of prescription drug coverage information for purposes of identifying primary payer situations under the Medicare program
Sec. 1001At-risk youth Medicaid protection
Sec. 1001Definitions
Sec. 1001At-risk youth Medicaid protection
Sec. 1001At-risk youth Medicaid protection
Sec. 1001At-risk youth Medicaid protection
Sec. 1002Health insurance for former foster youth
Sec. 1002Health Insurance for Former Foster Youth
Sec. 1002Health insurance for former foster youth
Sec. 1002Health Insurance for Former Foster Youth
Sec. 1003Demonstration project to increase substance use provider capacity under the Medicaid program
Sec. 1003Demonstration project to increase substance use provider capacity under the Medicaid program
Sec. 1003Demonstration project to increase substance use provider capacity under the Medicaid program
Sec. 1003Demonstration project to increase substance use provider capacity under the Medicaid program
Sec. 1004Medicaid drug review and utilization
Sec. 1004Drug management program for at-risk beneficiaries
Sec. 1004Medicaid drug review and utilization
Sec. 1004Drug management program for at-risk beneficiaries
Sec. 1005Guidance to improve care for infants with neonatal abstinence syndrome and their mothers; GAO study on gaps in Medicaid coverage for pregnant and postpartum women with substance use disorder
Sec. 1005Medicaid drug review and utilization
Sec. 1005Guidance to improve care for infants with neonatal abstinence syndrome and their mothers; GAO study on gaps in Medicaid coverage for pregnant and postpartum women with substance use disorder
Sec. 1005Medicaid drug review and utilization
Sec. 1006Medicaid health homes for substance-use-disorder Medicaid enrollees
Sec. 1006Medicaid health homes for substance-use-disorder Medicaid enrollees
Sec. 1006Guidance to improve care for infants with neonatal abstinence syndrome and their mothers; GAO study on gaps in Medicaid coverage for pregnant and postpartum women with substance use disorder
Sec. 1006Guidance to improve care for infants with neonatal abstinence syndrome and their mothers; GAO study on gaps in Medicaid coverage for pregnant and postpartum women with substance use disorder
Sec. 1007Caring recovery for infants and babies
Sec. 1007Medicaid health homes for opioid-use-disorder Medicaid enrollees
Sec. 1007Caring recovery for infants and babies
Sec. 1007Medicaid health homes for opioid-use-disorder Medicaid enrollees
Sec. 1008Peer support enhancement and evaluation review
Sec. 1008Peer support enhancement and evaluation review
Sec. 1009Medicaid substance use disorder treatment via telehealth
Sec. 1009Medicaid substance use disorder treatment via telehealth
Sec. 1010Enhancing patient access to non-opioid treatment options
Sec. 1010Enhancing patient access to non-opioid treatment options
Sec. 1011Assessing barriers to opioid use disorder treatment
Sec. 1011Assessing barriers to opioid use disorder treatment
Sec. 1012Help for moms and babies
Sec. 1012Help for moms and babies
Sec. 1013Securing flexibility to treat substance use disorders
Sec. 1013Securing flexibility to treat substance use disorders
Sec. 1014MACPAC study and report on MAT utilization controls under State Medicaid programs
Sec. 1014MACPAC study and report on MAT utilization controls under State Medicaid programs
Sec. 1015Opioid addiction treatment programs enhancement
Sec. 1015Opioid addiction treatment programs enhancement
Sec. 1016Better data sharing to combat the opioid crisis
Sec. 1016Better data sharing to combat the opioid crisis
Sec. 1017Report on innovative State initiatives and strategies to provide housing-related services and supports to individuals struggling with substance use disorders under Medicaid
Sec. 1017Report on innovative State initiatives and strategies to provide housing-related services and supports to individuals struggling with substance use disorders under Medicaid
Sec. 1018Technical assistance and support for innovative State strategies to provide housing-related supports under Medicaid
Sec. 1018Technical assistance and support for innovative State strategies to provide housing-related supports under Medicaid
Sec. 1101State response to the opioid abuse crisis
Sec. 1201Advancing cutting-edge research
Sec. 1202Pain research
Sec. 1203Report on synthetic drug use
Sec. 1301Clarifying FDA regulation of non-addictive pain products
Sec. 1302Clarifying FDA packaging authorities
Sec. 1303Strengthening FDA and CBP coordination and capacity
Sec. 1304Clarifying FDA post-market authorities
Sec. 1305Restricting entrance of illicit drugs
Sec. 1306First responder training
Sec. 1307Disposal of controlled substances of hospice patients
Sec. 1308GAO study and report on hospice safe drug management
Sec. 1309Delivery of a controlled substance by a pharmacy to be administered by injection or implantation
Sec. 1401Comprehensive opioid recovery centers
Sec. 1402Program to support coordination and continuation of care for drug overdose patients
Sec. 1403Alternatives to opioids
Sec. 1404Building communities of recovery
Sec. 1405Peer support technical assistance center
Sec. 1406Medication-assisted treatment for recovery from addiction
Sec. 1407Grant program
Sec. 1408Allowing for more flexibility with respect to medication-assisted treatment for opioid use disorders
Sec. 1409National recovery housing best practices
Sec. 1410Addressing economic and workforce impacts of the opioid crisis
Sec. 1411Career Act
Sec. 1412Pilot program to help individuals in recovery from a substance use disorder become stably housed
Sec. 1413Youth prevention and recovery
Sec. 1414Plans of safe care
Sec. 1415Regulations relating to special registration for telemedicine
Sec. 1416National Health Service Corps behavioral and mental health professionals providing obligated service in schools and other community-based settings
Sec. 1417Loan repayment for substance use disorder treatment providers
Sec. 1418Protecting moms and infants
Sec. 1419Early interventions for pregnant women and infants
Sec. 1420Report on investigations regarding parity in mental health and substance use disorder benefits
Sec. 1501Study on prescribing limits
Sec. 1502Programs for health care workforce
Sec. 1503Education and awareness campaigns
Sec. 1504Enhanced controlled substance overdoses data collection, analysis, and dissemination
Sec. 1505Preventing overdoses of controlled substances
Sec. 1506CDC surveillance and data collection for child, youth, and adult trauma
Sec. 1507Reauthorization of NASPER
Sec. 1508Jessie’s law
Sec. 1509Development and dissemination of model training programs for substance use disorder patient records
Sec. 1510Communication with families during emergencies
Sec. 1511Prenatal and postnatal health
Sec. 1512Surveillance and education regarding infections associated with illicit drug use and other risk factors
Sec. 1513Task force to develop best practices for trauma-informed identification, referral, and support
Sec. 1514Grants to improve trauma support services and mental health care for children and youth in educational settings
Sec. 1515National Child Traumatic Stress Initiative
Sec. 1516National milestones to measure success in curtailing the opioid crisis
Sec. 2001Expanding the use of telehealth services for the treatment of opioid use disorder and other substance use disorders
Sec. 2001Short title
Sec. 2001Authority not to apply certain Medicare telehealth requirements in the case of certain treatment of a substance use disorder or co-occurring mental health disorder
Sec. 2001Expanding the use of telehealth services for the treatment of opioid use disorder and other substance use disorders
Sec. 2001Authority not to apply certain Medicare telehealth requirements in the case of certain treatment of a substance use disorder or co-occurring mental health disorder
Sec. 2002Comprehensive screenings for seniors
Sec. 2002Encouraging the use of non-opioid analgesics for the management of post-surgical pain
Sec. 2002Comprehensive screenings for seniors
Sec. 2002Encouraging the use of non-opioid analgesics for the management of post-surgical pain
Sec. 2003Every prescription conveyed securely
Sec. 2003Requiring a review of current opioid prescriptions for chronic pain and screening for opioid use disorder to be included in the Welcome to Medicare initial preventive physical examination
Sec. 2003Every prescription conveyed securely
Sec. 2003Requiring a review of current opioid prescriptions for chronic pain and screening for opioid use disorder to be included in the Welcome to Medicare initial preventive physical examination
Sec. 2004Requiring prescription drug plan sponsors under Medicare to establish drug management programs for at-risk beneficiaries
Sec. 2004Modification of payment for certain outpatient surgical services
Sec. 2004Requiring prescription drug plan sponsors under Medicare to establish drug management programs for at-risk beneficiaries
Sec. 2004Modification of payment for certain outpatient surgical services
Sec. 2005Medicare coverage of certain services furnished by opioid treatment programs
Sec. 2005Requiring e-prescribing for coverage of covered part D controlled substances
Sec. 2005Medicare coverage of certain services furnished by opioid treatment programs
Sec. 2005Requiring e-prescribing for coverage of covered part D controlled substances
Sec. 2006Encouraging appropriate prescribing under Medicare for victims of opioid overdose
Sec. 2006Requiring prescription drug plan sponsors under Medicare to establish drug management programs for at-risk beneficiaries
Sec. 2006Encouraging appropriate prescribing under Medicare for victims of opioid overdose
Sec. 2006Requiring prescription drug plan sponsors under Medicare to establish drug management programs for at-risk beneficiaries
Sec. 2007Automatic escalation to external review under a Medicare part D drug management program for at-risk beneficiaries
Sec. 2007Medicare coverage of certain services furnished by opioid treatment programs
Sec. 2007Automatic escalation to external review under a Medicare part D drug management program for at-risk beneficiaries
Sec. 2007Medicare coverage of certain services furnished by opioid treatment programs
Sec. 2008Suspension of payments by Medicare prescription drug plans and MA–PD plans pending investigations of credible allegations of fraud by pharmacies
Sec. 2008Suspension of payments by Medicare prescription drug plans and MA–PD plans pending investigations of credible allegations of fraud by pharmacies
Sec. 2101Medicare opioid safety education
Sec. 2102Expanding the use of telehealth services for the treatment of opioid use disorder and other substance use disorders
Sec. 2103Comprehensive screenings for seniors
Sec. 2104Every prescription conveyed securely
Sec. 2105Standardizing electronic prior authorization for safe prescribing
Sec. 2106Strengthening partnerships to prevent opioid abuse
Sec. 2107Commit to opioid medical prescriber accountability and safety for seniors
Sec. 2108Fighting the opioid epidemic with sunshine
Sec. 2109Demonstration testing coverage of certain services furnished by opioid treatment programs
Sec. 2110Encouraging appropriate prescribing under Medicare for victims of opioid overdose
Sec. 2111Automatic escalation to external review under a Medicare part D drug management program for at-risk beneficiaries
Sec. 2112Testing of incentive payments for behavioral health providers for adoption and use of certified electronic health record technology
Sec. 2113Medicare Improvement Fund
Sec. 2201Caring recovery for infants and babies
Sec. 2202Peer support enhancement and evaluation review
Sec. 2203Medicaid substance use disorder treatment via telehealth
Sec. 2204Enhancing patient access to non-opioid treatment options
Sec. 2205Assessing barriers to opioid use disorder treatment
Sec. 2206Help for moms and babies
Sec. 2207Securing flexibility to treat substance use disorders
Sec. 2208MACPAC study and report on MAT utilization controls under State Medicaid programs
Sec. 2209Opioid addiction treatment programs enhancement
Sec. 2210Better data sharing to combat the opioid crisis
Sec. 2211Mandatory reporting with respect to adult behavioral health measures
Sec. 2212Report on innovative State initiatives and strategies to provide housing-related services and supports to individuals struggling with substance use disorders under Medicaid
Sec. 2213Technical assistance and support for innovative State strategies to provide housing-related supports under Medicaid
Sec. 2301Supporting family-focused residential treatment
Sec. 2302Improving recovery and reunifying families
Sec. 2303Building capacity for family-focused residential treatment
Sec. 2401Short title
Sec. 2402Customs fees
Sec. 2403Mandatory advance electronic information for postal shipments
Sec. 2404International postal agreements
Sec. 2405Cost recoupment
Sec. 2406Development of technology to detect illicit narcotics
Sec. 2407Civil penalties for postal shipments
Sec. 2408Report on violations of arrival, reporting, entry, and clearance requirements and falsity or lack of manifest
Sec. 2409Effective date; regulations
Sec. 3001Clarifying FDA regulation of non-addictive pain products
Sec. 3001Clarifying FDA regulation of non-addictive pain and addiction therapies
Sec. 3001Clarifying FDA regulation of non-addictive pain products
Sec. 3001Clarifying FDA regulation of non-addictive pain and addiction therapies
Sec. 3002Evidence-based opioid analgesic prescribing guidelines and report
Sec. 3002Surveillance and Testing of Opioids to Prevent Fentanyl Deaths
Sec. 3002Evidence-based opioid analgesic prescribing guidelines and report
Sec. 3002Surveillance and Testing of Opioids to Prevent Fentanyl Deaths
Sec. 3003Allowing for more flexibility with respect to medication-assisted treatment for opioid use disorders
Sec. 3003Allowing for more flexibility with respect to medication-assisted treatment for opioid use disorders
Sec. 3004High-quality, evidence-based opioid analgesic prescribing guidelines and report
Sec. 3004High-quality, evidence-based opioid analgesic prescribing guidelines and report
Sec. 3005Report on opioids prescribing practices for pregnant women
Sec. 3005Report on opioids prescribing practices for pregnant women
Sec. 3006Guidelines for prescribing naloxone
Sec. 3006Guidelines for prescribing naloxone
Sec. 3007Requiring a survey of substance use disorder treatment providers receiving Federal funding
Sec. 3007Requiring a survey of substance use disorder treatment providers receiving Federal funding
Sec. 3011Short title
Sec. 3011Short title
Sec. 3012Notification, nondistribution, and recall of controlled substances
Sec. 3012Notification, nondistribution, and recall of controlled substances
Sec. 3013Single source pattern of imported illegal drugs
Sec. 3013Single source pattern of imported illegal drugs
Sec. 3014Strengthening FDA and CBP coordination and capacity
Sec. 3014Strengthening FDA and CBP coordination and capacity
Sec. 3021Short title
Sec. 3021Short title
Sec. 3022Restricting entrance of illicit drugs
Sec. 3022Restricting entrance of illicit drugs
Sec. 3031Short title
Sec. 3031Short title
Sec. 3032Safety-enhancing packaging and disposal features
Sec. 3032Safety-enhancing packaging and disposal features
Sec. 3041Clarifying FDA postmarket authorities
Sec. 3041Clarifying FDA postmarket authorities
Sec. 3101Short title
Sec. 3102Definitions
Sec. 3103Authority to make grants
Sec. 3104Application
Sec. 3105Use of grant funds
Sec. 3106Eligibility for grant
Sec. 3107Duration of grants
Sec. 3108Accountability and oversight
Sec. 3109Duration of program
Sec. 3110Authorization of appropriations
Sec. 3201Allowing for more flexibility with respect to medication-assisted treatment for opioid use disorders
Sec. 3201Short title
Sec. 3201Allowing for more flexibility with respect to medication-assisted treatment for opioid use disorders
Sec. 3202Medication-assisted treatment for recovery from substance use disorder
Sec. 3202Purpose
Sec. 3202Medication-assisted treatment for recovery from substance use disorder
Sec. 3203Grants to enhance access to substance use disorder treatment
Sec. 3203Amendments
Sec. 3203Grants to enhance access to substance use disorder treatment
Sec. 3204Delivery of a controlled substance by a pharmacy to be administered by injection or implantation
Sec. 3204Report
Sec. 3204Delivery of a controlled substance by a pharmacy to be administered by injection or implantation
Sec. 3211Short title
Sec. 3211Short title
Sec. 3212Programs and materials for training on certain circumstances under which a pharmacist may decline to fill a prescription
Sec. 3212Programs and materials for training on certain circumstances under which a pharmacist may decline to fill a prescription
Sec. 3221Short title
Sec. 3221Short title
Sec. 3222Disposal of controlled substances of a hospice patient by employees of a qualified hospice program
Sec. 3222Disposal of controlled substances of a hospice patient by employees of a qualified hospice program
Sec. 3223GAO study and report on hospice safe drug management
Sec. 3223GAO study and report on hospice safe drug management
Sec. 3231Short title
Sec. 3231Short title
Sec. 3232Regulations relating to a special registration for telemedicine
Sec. 3232Regulations relating to a special registration for telemedicine
Sec. 3241Controlled substance analogues
Sec. 3241Controlled substance analogues
Sec. 3251Short title
Sec. 3251Short title
Sec. 3252Definitions
Sec. 3252Definitions
Sec. 3253Authority to make grants
Sec. 3253Authority to make grants
Sec. 3254Application
Sec. 3254Application
Sec. 3255Use of grant funds
Sec. 3255Use of grant funds
Sec. 3256Eligibility for grant
Sec. 3256Eligibility for grant
Sec. 3257Duration of grants
Sec. 3257Duration of grants
Sec. 3258Accountability and oversight
Sec. 3258Accountability and oversight
Sec. 3259Duration of program
Sec. 3259Duration of program
Sec. 3260Authorization of appropriations
Sec. 3260Authorization of appropriations
Sec. 3271Short title
Sec. 3271Short title
Sec. 3272Purpose
Sec. 3272Purpose
Sec. 3273Amendments
Sec. 3273Amendments
Sec. 3274Report
Sec. 3274Report
Sec. 3281Short title
Sec. 3281Short title
Sec. 3282Strengthening considerations for DEA opioid quotas
Sec. 3282Strengthening considerations for DEA opioid quotas
Sec. 3291Short title
Sec. 3291Short title
Sec. 3292Improvements to prevent drug diversion
Sec. 3292Improvements to prevent drug diversion
Sec. 3301Short title
Sec. 3302Reauthorization of the Office of National Drug Control Policy
Sec. 3303Reauthorization of the Drug-Free Communities Program
Sec. 3304Reauthorization of the National Community Anti-Drug Coalition Institute
Sec. 3305Reauthorization of the High-Intensity Drug Trafficking Area Program
Sec. 3306Reauthorization of drug court program
Sec. 3307Drug court training and technical assistance
Sec. 3308Drug overdose response strategy
Sec. 3309Protecting law enforcement officers from accidental exposure
Sec. 3310COPS Anti-Meth Program
Sec. 3311COPS anti-heroin task force program
Sec. 3312Comprehensive Addiction and Recovery Act education and awareness
Sec. 3313Protecting children with addicted parents
Sec. 3314Reimbursement of substance use disorder treatment professionals
Sec. 3315Sobriety Treatment and Recovery Teams (START)
Sec. 3316Provider education
Sec. 3317Demand reduction
Sec. 3318Anti-drug media campaign
Sec. 3319Technical corrections to the office of national drug control policy reauthorization act of 1998
Sec. 3401Short title
Sec. 3402Controlled substance analogues
Sec. 3501Short title
Sec. 3502Strengthening considerations for DEA opioid quotas
Sec. 3601Short title
Sec. 3602Improvements to prevent drug diversion
Sec. 3701Sense of Congress
Sec. 4001Promoting value in Medicaid managed care
Sec. 4001Promoting value in Medicaid managed care
Sec. 4001Promoting value in Medicaid managed care
Sec. 4001Promoting value in Medicaid managed care
Sec. 4002Requiring reporting by group health plans of prescription drug coverage information for purposes of identifying primary payer situations under the Medicare program
Sec. 4002Extending period of application of Medicare secondary payer rules for individuals with end stage renal disease
Sec. 4002Requiring reporting by group health plans of prescription drug coverage information for purposes of identifying primary payer situations under the Medicare program
Sec. 4002Extending period of application of Medicare secondary payer rules for individuals with end stage renal disease
Sec. 4003Additional religious exemption from health coverage responsibility requirement
Sec. 4003Requiring reporting by group health plans of prescription drug coverage information for purposes of identifying primary payer situations under the Medicare program
Sec. 4003Additional religious exemption from health coverage responsibility requirement
Sec. 4003Requiring reporting by group health plans of prescription drug coverage information for purposes of identifying primary payer situations under the Medicare program
Sec. 4004Modernizing the reporting of biological and biosimilar products
Sec. 4004Modernizing the reporting of biological and biosimilar products
Sec. 4101Short title
Sec. 4102Rail mechanical employee controlled substances and alcohol testing
Sec. 4103Rail yardmaster controlled substances and alcohol testing
Sec. 4104Department of Transportation public drug and alcohol testing database
Sec. 4105GAO report on Department of Transportation’s collection and use of drug and alcohol testing data
Sec. 4106Transportation Workplace Drug and Alcohol Testing Program; addition of fentanyl
Sec. 4107Status reports on hair testing guidelines
Sec. 4108Mandatory Guidelines for Federal Workplace Drug Testing Programs Using Oral Fluid
Sec. 4109Electronic recordkeeping
Sec. 4110Status reports on Commercial Driver's License Drug and Alcohol Clearinghouse
Sec. 4201Short title
Sec. 4202Definitions
Sec. 4203False or misleading representations with respect to opioid treatment programs and products
Sec. 5001Mandatory reporting with respect to adult behavioral health measures
Sec. 5001Mandatory reporting with respect to adult behavioral health measures
Sec. 5001Mandatory reporting with respect to adult behavioral health measures
Sec. 5001Mandatory reporting with respect to adult behavioral health measures
Sec. 5011Short title
Sec. 5011Short title
Sec. 5011Short title
Sec. 5011Short title
Sec. 5012MACPAC exploratory study and report on institutions for mental diseases requirements and practices under Medicaid
Sec. 5012MACPAC exploratory study and report on institutions for mental diseases requirements and practices under Medicaid
Sec. 5012MACPAC exploratory study and report on institutions for mental diseases requirements and practices under Medicaid
Sec. 5012MACPAC exploratory study and report on institutions for mental diseases requirements and practices under Medicaid
Sec. 5021Short title
Sec. 5021Short title
Sec. 5021Short title
Sec. 5021Short title
Sec. 5022Ensuring access to mental health and substance use disorder services for children and pregnant women under the Children’s Health Insurance Program
Sec. 5022Ensuring access to mental health and substance use disorder services for children and pregnant women under the Children’s Health Insurance Program
Sec. 5022Ensuring access to mental health and substance use disorder services for children and pregnant women under the Children’s Health Insurance Program
Sec. 5022Ensuring access to mental health and substance use disorder services for children and pregnant women under the Children’s Health Insurance Program
Sec. 5031Short title
Sec. 5031Short title
Sec. 5031Short title
Sec. 5031Short title
Sec. 5032Promoting State innovations to ease transitions integration to the community for certain individuals
Sec. 5032Promoting State innovations to ease transitions integration to the community for certain individuals
Sec. 5032Promoting State innovations to ease transitions integration to the community for certain individuals
Sec. 5032Promoting State innovations to ease transitions integration to the community for certain individuals
Sec. 5041Short title
Sec. 5041Short title
Sec. 5041Short title
Sec. 5041Short title
Sec. 5042Medicaid providers are required to note experiences in record systems to help in-need patients
Sec. 5042Medicaid providers are required to note experiences in record systems to help in-need patients
Sec. 5042Medicaid providers are required to note experiences in record systems to help in-need patients
Sec. 5042Medicaid providers are required to note experiences in record systems to help in-need patients
Sec. 5051Short title
Sec. 5051Short title
Sec. 5052State option to provide Medicaid coverage for certain individuals with substance use disorders who are patients in certain institutions for mental diseases
Sec. 5052State option to provide Medicaid coverage for certain individuals with substance use disorders who are patients in certain institutions for mental diseases
Sec. 5061Medicaid Improvement Fund
Sec. 5061Medicaid Improvement Fund
Sec. 6001Testing of incentive payments for behavioral health providers for adoption and use of certified electronic health record technology
Sec. 6001Testing of incentive payments for behavioral health providers for adoption and use of certified electronic health record technology
Sec. 6001Testing of incentive payments for behavioral health providers for adoption and use of certified electronic health record technology
Sec. 6001Testing of incentive payments for behavioral health providers for adoption and use of certified electronic health record technology
Sec. 6011Short title
Sec. 6011Short title
Sec. 6011Short title
Sec. 6011Short title
Sec. 6012Study on abuse-deterrent opioid formulations access barriers under Medicare
Sec. 6012Study on abuse-deterrent opioid formulations access barriers under Medicare
Sec. 6012Study on abuse-deterrent opioid formulations access barriers under Medicare
Sec. 6012Study on abuse-deterrent opioid formulations access barriers under Medicare
Sec. 6021Medicare opioid safety education
Sec. 6021Short title
Sec. 6021Medicare opioid safety education
Sec. 6021Short title
Sec. 6022Provision of information regarding opioid use and pain management as part of Medicare & You handbook
Sec. 6022Provision of information regarding opioid use and pain management as part of Medicare & You handbook
Sec. 6031Short title
Sec. 6031Short title
Sec. 6031Short title
Sec. 6031Short title
Sec. 6032Action plan on recommendations for changes under Medicare and Medicaid to prevent opioids addictions and enhance access to medication-assisted treatment
Sec. 6032Action plan on recommendations for changes under Medicare and Medicaid to prevent opioids addictions and enhance access to medication-assisted treatment
Sec. 6032Action plan on recommendations for changes under Medicare and Medicaid to prevent opioids addictions and enhance access to medication-assisted treatment
Sec. 6032Action plan on recommendations for changes under Medicare and Medicaid to prevent opioids addictions and enhance access to medication-assisted treatment
Sec. 6041Short title
Sec. 6041Short title
Sec. 6041Short title
Sec. 6041Short title
Sec. 6042Opioid use disorder treatment demonstration program
Sec. 6042Opioid use disorder treatment demonstration program
Sec. 6042Opioid use disorder treatment demonstration program
Sec. 6042Opioid use disorder treatment demonstration program
Sec. 6051Short title
Sec. 6051Short title
Sec. 6051Short title
Sec. 6051Short title
Sec. 6052Grants to provide technical assistance to outlier prescribers of opioids
Sec. 6052Grants to provide technical assistance to outlier prescribers of opioids
Sec. 6052Grants to provide technical assistance to outlier prescribers of opioids
Sec. 6052Grants to provide technical assistance to outlier prescribers of opioids
Sec. 6061Short title
Sec. 6061Short title
Sec. 6061Short title
Sec. 6061Short title
Sec. 6062Electronic prior authorization for covered part D drugs
Sec. 6062Electronic prior authorization for covered part D drugs
Sec. 6062Electronic prior authorization for covered part D drugs
Sec. 6062Electronic prior authorization for covered part D drugs
Sec. 6063Program integrity transparency measures under Medicare parts C and D
Sec. 6063Program integrity transparency measures under Medicare parts C and D
Sec. 6063Program integrity transparency measures under Medicare parts C and D
Sec. 6063Program integrity transparency measures under Medicare parts C and D
Sec. 6064Expanding eligibility for medication therapy management programs under part D
Sec. 6064Expanding eligibility for medication therapy management programs under part D
Sec. 6064Expanding eligibility for medication therapy management programs under part D
Sec. 6064Expanding eligibility for medication therapy management programs under part D
Sec. 6065Commit to opioid medical prescriber accountability and safety for seniors
Sec. 6065Medicare notifications to outlier prescribers of opioids
Sec. 6065Commit to opioid medical prescriber accountability and safety for seniors
Sec. 6065Medicare notifications to outlier prescribers of opioids
Sec. 6066No additional funds authorized
Sec. 6066No additional funds authorized
Sec. 6066No additional funds authorized
Sec. 6066No additional funds authorized
Sec. 6071Short title
Sec. 6071Short title
Sec. 6071Short title
Sec. 6071Short title
Sec. 6072Medicare Payment Advisory Commission report on opioid payment, adverse incentives, and data under the Medicare program
Sec. 6072Medicare Payment Advisory Commission report on opioid payment, adverse incentives, and data under the Medicare program
Sec. 6072Medicare Payment Advisory Commission report on opioid payment, adverse incentives, and data under the Medicare program
Sec. 6072Medicare Payment Advisory Commission report on opioid payment, adverse incentives, and data under the Medicare program
Sec. 6073No additional funds authorized
Sec. 6073No additional funds authorized
Sec. 6073No additional funds authorized
Sec. 6073No additional funds authorized
Sec. 6081Short title
Sec. 6081Short title
Sec. 6081Short title
Sec. 6081Short title
Sec. 6082Review and adjustment of payments under the Medicare outpatient prospective payment system to avoid financial incentives to use opioids instead of non-opioid alternative treatments
Sec. 6082Review and adjustment of payments under the Medicare outpatient prospective payment system to avoid financial incentives to use opioids instead of non-opioid alternative treatments
Sec. 6082Review and adjustment of payments under the Medicare outpatient prospective payment system to avoid financial incentives to use opioids instead of non-opioid alternative treatments
Sec. 6082Review and adjustment of payments under the Medicare outpatient prospective payment system to avoid financial incentives to use opioids instead of non-opioid alternative treatments
Sec. 6083Expanding access under the Medicare program to addiction treatment in Federally qualified health centers and rural health clinics
Sec. 6083Expanding access under the Medicare program to addiction treatment in Federally qualified health centers and rural health clinics
Sec. 6083Expanding access under the Medicare program to addiction treatment in Federally qualified health centers and rural health clinics
Sec. 6083Expanding access under the Medicare program to addiction treatment in Federally qualified health centers and rural health clinics
Sec. 6084Studying the availability of supplemental benefits designed to treat or prevent substance use disorders under Medicare Advantage plans
Sec. 6084Studying the availability of supplemental benefits designed to treat or prevent substance use disorders under Medicare Advantage plans
Sec. 6084Studying the availability of supplemental benefits designed to treat or prevent substance use disorders under Medicare Advantage plans
Sec. 6084Studying the availability of supplemental benefits designed to treat or prevent substance use disorders under Medicare Advantage plans
Sec. 6085Clinical psychologist services models under the Center for Medicare and Medicaid Innovation; GAO study and report
Sec. 6085Clinical psychologist services models under the Center for Medicare and Medicaid Innovation; GAO study and report
Sec. 6085Clinical psychologist services models under the Center for Medicare and Medicaid Innovation; GAO study and report
Sec. 6085Clinical psychologist services models under the Center for Medicare and Medicaid Innovation; GAO study and report
Sec. 6086Dr. Todd Graham pain management study
Sec. 6086Pain management study
Sec. 6086Dr. Todd Graham pain management study
Sec. 6086Pain management study
Sec. 6091Short title
Sec. 6091Short title
Sec. 6091Short title
Sec. 6091Short title
Sec. 6092Developing guidance on pain management and opioid use disorder prevention for hospitals receiving payment under part A of the Medicare program
Sec. 6092Developing guidance on pain management and opioid use disorder prevention for hospitals receiving payment under part A of the Medicare program
Sec. 6092Developing guidance on pain management and opioid use disorder prevention for hospitals receiving payment under part A of the Medicare program
Sec. 6092Developing guidance on pain management and opioid use disorder prevention for hospitals receiving payment under part A of the Medicare program
Sec. 6093Requiring the review of quality measures relating to opioids and opioid use disorder treatments furnished under the medicare program and other federal health care programs
Sec. 6093Requiring the review of quality measures relating to opioids and opioid use disorder treatments furnished under the medicare program and other federal health care programs
Sec. 6093Requiring the review of quality measures relating to opioids and opioid use disorder treatments furnished under the medicare program and other federal health care programs
Sec. 6093Requiring the review of quality measures relating to opioids and opioid use disorder treatments furnished under the medicare program and other federal health care programs
Sec. 6094Technical expert panel on reducing surgical setting opioid use; Data collection on perioperative opioid use
Sec. 6094Technical expert panel on reducing surgical setting opioid use; Data collection on perioperative opioid use
Sec. 6094Technical expert panel on reducing surgical setting opioid use; Data collection on perioperative opioid use
Sec. 6094Technical expert panel on reducing surgical setting opioid use; Data collection on perioperative opioid use
Sec. 6095Requiring the posting and periodic update of opioid prescribing guidance for Medicare beneficiaries
Sec. 6095Requiring the posting and periodic update of opioid prescribing guidance for Medicare beneficiaries
Sec. 6095Requiring the posting and periodic update of opioid prescribing guidance for Medicare beneficiaries
Sec. 6095Requiring the posting and periodic update of opioid prescribing guidance for Medicare beneficiaries
Sec. 6101Short title
Sec. 6101Short title
Sec. 6101Short title
Sec. 6101Short title
Sec. 6102Requiring Medicare Advantage plans and part D prescription drug plans to include information on risks associated with opioids and coverage of nonpharmacological therapies and nonopioid medications or devices used to treat pain
Sec. 6102Suspension of payments by Medicare prescription drug plans and MA–PD plans pending investigations of credible allegations of fraud by pharmacies
Sec. 6102Requiring Medicare Advantage plans and part D prescription drug plans to include information on risks associated with opioids and coverage of nonpharmacological therapies and nonopioid medications or devices used to treat pain
Sec. 6102Suspension of payments by Medicare prescription drug plans and MA–PD plans pending investigations of credible allegations of fraud by pharmacies
Sec. 6103Requiring Medicare Advantage plans and prescription drug plans to provide information on the safe disposal of prescription drugs
Sec. 6103Requiring Medicare Advantage plans and prescription drug plans to provide information on the safe disposal of prescription drugs
Sec. 6104Revising measures used under the Hospital Consumer Assessment of Healthcare Providers and Systems survey relating to pain management
Sec. 6104Revising measures used under the Hospital Consumer Assessment of Healthcare Providers and Systems survey relating to pain management
Sec. 6111Fighting the opioid epidemic with sunshine
Sec. 6111Short title
Sec. 6111Fighting the opioid epidemic with sunshine
Sec. 6111Short title
Sec. 6112Requiring Medicare Advantage plans and part D prescription drug plans to include information on risks associated with opioids and coverage of nonpharmacological therapies and nonopioid medications or devices used to treat pain
Sec. 6112Requiring Medicare Advantage plans and part D prescription drug plans to include information on risks associated with opioids and coverage of nonpharmacological therapies and nonopioid medications or devices used to treat pain
Sec. 6113Requiring Medicare Advantage plans and prescription drug plans to provide information on the safe disposal of prescription drugs
Sec. 6113Requiring Medicare Advantage plans and prescription drug plans to provide information on the safe disposal of prescription drugs
Sec. 6114Revising measures used under the Hospital Consumer Assessment of Healthcare Providers and Systems survey relating to pain management
Sec. 6114Revising measures used under the Hospital Consumer Assessment of Healthcare Providers and Systems survey relating to pain management
Sec. 7001Report on effects on public health of synthetic drug use
Sec. 7001Short title
Sec. 7001Report on effects on public health of synthetic drug use
Sec. 7001Short title
Sec. 7002First responder training
Sec. 7002Report on effects on public health of synthetic drug use
Sec. 7002First responder training
Sec. 7002Report on effects on public health of synthetic drug use
Sec. 7011Pilot program for public health laboratories to detect fentanyl and other synthetic opioids
Sec. 7011Short title
Sec. 7011Pilot program for public health laboratories to detect fentanyl and other synthetic opioids
Sec. 7011Short title
Sec. 7012Programs and materials for training on certain circumstances under which a pharmacist may decline to fill a prescription
Sec. 7012Programs and materials for training on certain circumstances under which a pharmacist may decline to fill a prescription
Sec. 7021Establishment of substance use disorder information dashboard
Sec. 7021Short title
Sec. 7021Establishment of substance use disorder information dashboard
Sec. 7021Short title
Sec. 7022Interdepartmental Substance Use Disorders Coordinating Committee
Sec. 7022Establishment of substance use disorder information dashboard
Sec. 7022Interdepartmental Substance Use Disorders Coordinating Committee
Sec. 7022Establishment of substance use disorder information dashboard
Sec. 7023National milestones to measure success in curtailing the opioid crisis
Sec. 7023Interagency Substance Use Disorder Coordinating Committee
Sec. 7023National milestones to measure success in curtailing the opioid crisis
Sec. 7023Interagency Substance Use Disorder Coordinating Committee
Sec. 7024Study on prescribing limits
Sec. 7024Study on prescribing limits
Sec. 7031National recovery housing best practices
Sec. 7031Short title
Sec. 7031National recovery housing best practices
Sec. 7031Short title
Sec. 7032National recovery housing best practices
Sec. 7032National recovery housing best practices
Sec. 7041Unique research initiatives
Sec. 7041Short title
Sec. 7041Unique research initiatives
Sec. 7041Short title
Sec. 7042Pain research
Sec. 7042Unique research initiatives
Sec. 7042Pain research
Sec. 7042Unique research initiatives
Sec. 7051Inclusion of opioid addiction history in patient records
Sec. 7051Short title
Sec. 7051Inclusion of opioid addiction history in patient records
Sec. 7051Short title
Sec. 7052Communication with families during emergencies
Sec. 7052Inclusion of opioid addiction history in patient records
Sec. 7052Communication with families during emergencies
Sec. 7052Inclusion of opioid addiction history in patient records
Sec. 7053Development and dissemination of model training programs for substance use disorder patient records
Sec. 7053Communication with families during emergencies
Sec. 7053Development and dissemination of model training programs for substance use disorder patient records
Sec. 7053Communication with families during emergencies
Sec. 7061Report on addressing maternal and infant health in the opioid crisis
Sec. 7061Short title
Sec. 7061Report on addressing maternal and infant health in the opioid crisis
Sec. 7061Short title
Sec. 7062Protecting moms and infants
Sec. 7062Disposal of controlled substances of a deceased hospice patient by employees of a qualified hospice program
Sec. 7062Protecting moms and infants
Sec. 7062Disposal of controlled substances of a deceased hospice patient by employees of a qualified hospice program
Sec. 7063Early interventions for pregnant women and infants
Sec. 7063Early interventions for pregnant women and infants
Sec. 7064Prenatal and postnatal health
Sec. 7064Prenatal and postnatal health
Sec. 7065Plans of safe care
Sec. 7065Plans of safe care
Sec. 7071Loan repayment program for substance use disorder treatment workforce
Sec. 7071Short title
Sec. 7071Loan repayment program for substance use disorder treatment workforce
Sec. 7071Short title
Sec. 7072Clarification regarding service in schools and other community-based settings
Sec. 7072Loan repayment program for substance use disorder treatment employees
Sec. 7072Clarification regarding service in schools and other community-based settings
Sec. 7072Loan repayment program for substance use disorder treatment employees
Sec. 7073Programs for health care workforce
Sec. 7073Programs for health care workforce
Sec. 7081Program to support coordination and continuation of care for drug overdose patients
Sec. 7081Short title
Sec. 7081Program to support coordination and continuation of care for drug overdose patients
Sec. 7081Short title
Sec. 7082Program to support emergency room discharge and care coordination for drug overdose patients
Sec. 7082Program to support emergency room discharge and care coordination for drug overdose patients
Sec. 7091Emergency department alternatives to opioids demonstration program
Sec. 7091Short title
Sec. 7091Emergency department alternatives to opioids demonstration program
Sec. 7091Short title
Sec. 7092Emergency department alternatives to opioids demonstration program
Sec. 7092Emergency department alternatives to opioids demonstration program
Sec. 7101Establishment of regional centers of excellence in substance use disorder education
Sec. 7101Short title
Sec. 7101Establishment of regional centers of excellence in substance use disorder education
Sec. 7101Short title
Sec. 7102Youth prevention and recovery
Sec. 7102Detention, refusal, and destruction of drugs offered for importation
Sec. 7102Youth prevention and recovery
Sec. 7102Detention, refusal, and destruction of drugs offered for importation
Sec. 7103Notification, nondistribution, and recall of adulterated or misbranded drug products
Sec. 7103Notification, nondistribution, and recall of adulterated or misbranded drug products
Sec. 7104Single source pattern of shipments of adulterated or misbranded drugs
Sec. 7104Single source pattern of shipments of adulterated or misbranded drugs
Sec. 7105Fund to strengthen efforts of FDA to combat the opioid and substance use epidemic
Sec. 7105Fund to strengthen efforts of FDA to combat the opioid and substance use epidemic
Sec. 7106Consideration of potential for misuse and abuse required for drug approval
Sec. 7106Consideration of potential for misuse and abuse required for drug approval
Sec. 7111Information from National Mental Health and Substance Use Policy Laboratory
Sec. 7111Short title
Sec. 7111Information from National Mental Health and Substance Use Policy Laboratory
Sec. 7111Short title
Sec. 7112Establishment of Regional Centers of Excellence in Substance Use Disorder Education
Sec. 7112Establishment of Regional Centers of Excellence in Substance Use Disorder Education
Sec. 7121Comprehensive opioid recovery centers
Sec. 7121Guidance from National Mental Health and Substance Use Policy Laboratory
Sec. 7121Comprehensive opioid recovery centers
Sec. 7121Guidance from National Mental Health and Substance Use Policy Laboratory
Sec. 7131CDC surveillance and data collection for child, youth, and adult trauma
Sec. 7131Short title
Sec. 7131CDC surveillance and data collection for child, youth, and adult trauma
Sec. 7131Short title
Sec. 7132Task force to develop best practices for trauma-informed identification, referral, and support
Sec. 7132Comprehensive opioid recovery centers
Sec. 7132Task force to develop best practices for trauma-informed identification, referral, and support
Sec. 7132Comprehensive opioid recovery centers
Sec. 7133National Child Traumatic Stress Initiative
Sec. 7133National Child Traumatic Stress Initiative
Sec. 7134Grants to improve trauma support services and mental health care for children and youth in educational settings
Sec. 7134Grants to improve trauma support services and mental health care for children and youth in educational settings
Sec. 7135Recognizing early childhood trauma related to substance abuse
Sec. 7135Recognizing early childhood trauma related to substance abuse
Sec. 7141Short title
Sec. 7141Reauthorization and expansion of program of surveillance and education regarding infections associated with illicit drug use and other risk factors
Sec. 7141Short title
Sec. 7141Reauthorization and expansion of program of surveillance and education regarding infections associated with illicit drug use and other risk factors
Sec. 7142Reauthorization of poison control centers national toll-free number
Sec. 7142Reauthorization of poison control centers national toll-free number
Sec. 7143Reauthorization of nationwide public awareness campaign to promote poison control center utilization
Sec. 7143Reauthorization of nationwide public awareness campaign to promote poison control center utilization
Sec. 7144Reauthorization of the poison control center grant program
Sec. 7144Reauthorization of the poison control center grant program
Sec. 7151Building communities of recovery
Sec. 7151Short title
Sec. 7151Building communities of recovery
Sec. 7151Short title
Sec. 7152Peer support technical assistance center
Sec. 7152Reauthorization and expansion of program of surveillance and education regarding infections associated with illicit drug use and other risk factors
Sec. 7152Peer support technical assistance center
Sec. 7152Reauthorization and expansion of program of surveillance and education regarding infections associated with illicit drug use and other risk factors
Sec. 7161Preventing overdoses of controlled substances
Sec. 7161Short title
Sec. 7161Preventing overdoses of controlled substances
Sec. 7161Short title
Sec. 7162Prescription drug monitoring program
Sec. 7162Guidance addressing alternative approaches to data collection and labeling claims for opioid sparing
Sec. 7162Prescription drug monitoring program
Sec. 7162Guidance addressing alternative approaches to data collection and labeling claims for opioid sparing
Sec. 7171Short title
Sec. 7171Review of substance use disorder treatment providers receiving Federal funding
Sec. 7171Short title
Sec. 7171Review of substance use disorder treatment providers receiving Federal funding
Sec. 7172Deadline for interim final regulations for a special registration To engage in the practice of telemedicine
Sec. 7172Deadline for interim final regulations for a special registration To engage in the practice of telemedicine
Sec. 7181State response to the opioid abuse crisis
Sec. 7181Short title
Sec. 7181State response to the opioid abuse crisis
Sec. 7181Short title
Sec. 7182Report on investigations regarding parity in mental health and substance use disorder benefits
Sec. 7182Building communities of recovery
Sec. 7182Report on investigations regarding parity in mental health and substance use disorder benefits
Sec. 7182Building communities of recovery
Sec. 7183CAREER Act
Sec. 7183CAREER Act
Sec. 7191Short title
Sec. 7191Short title
Sec. 7192Detention, refusal, and destruction of drugs offered for importation
Sec. 7192Detention, refusal, and destruction of drugs offered for importation
Sec. 7193Seizure
Sec. 7193Seizure
Sec. 7194Debarring violative individuals or companies
Sec. 7194Debarring violative individuals or companies
Sec. 7201Short title
Sec. 7201Short title
Sec. 7202Preventing overdoses of controlled substances
Sec. 7202Preventing overdoses of controlled substances
Sec. 7203Prescription drug monitoring program
Sec. 7203Prescription drug monitoring program
Sec. 7211Short title
Sec. 7211Short title
Sec. 7212Improved technologies, controls, or measures with respect to the packaging or disposal of certain drugs
Sec. 7212Improved technologies, controls, or measures with respect to the packaging or disposal of certain drugs
Sec. 7221Postapproval study requirements
Sec. 7221Postapproval study requirements
Sec. 8001Short title
Sec. 8001Short title; table of contents
Sec. 8001Short title
Sec. 8001Short title; table of contents
Sec. 8002Customs fees
Sec. 8002Customs fees
Sec. 8002Customs fees
Sec. 8002Customs fees
Sec. 8003Mandatory advance electronic information for postal shipments
Sec. 8003Mandatory advance electronic information for postal shipments
Sec. 8003Mandatory advance electronic information for postal shipments
Sec. 8003Mandatory advance electronic information for postal shipments
Sec. 8004International postal agreements
Sec. 8004International postal agreements
Sec. 8004International postal agreements
Sec. 8004International postal agreements
Sec. 8005Cost recoupment
Sec. 8005Cost recoupment
Sec. 8005Cost recoupment
Sec. 8005Cost recoupment
Sec. 8006Development of technology to detect illicit narcotics
Sec. 8006Development of technology to detect illicit narcotics
Sec. 8006Development of technology to detect illicit narcotics
Sec. 8006Development of technology to detect illicit narcotics
Sec. 8007Civil penalties for postal shipments
Sec. 8007Civil penalties for postal shipments
Sec. 8007Civil penalties for postal shipments
Sec. 8007Civil penalties for postal shipments
Sec. 8008Report on violations of arrival, reporting, entry, and clearance requirements and falsity or lack of manifest
Sec. 8008Report on violations of arrival, reporting, entry, and clearance requirements and falsity or lack of manifest
Sec. 8008Report on violations of arrival, reporting, entry, and clearance requirements and falsity or lack of manifest
Sec. 8008Report on violations of arrival, reporting, entry, and clearance requirements and falsity or lack of manifest
Sec. 8009Effective date; regulations
Sec. 8009Effective date; regulations
Sec. 8009Effective date; regulations
Sec. 8009Effective date; regulations
Sec. 8011Short title
Sec. 8011Short title
Sec. 8012Recognizing Early Childhood Trauma Related to Substance Abuse
Sec. 8012Recognizing Early Childhood Trauma Related to Substance Abuse
Sec. 8021Short title
Sec. 8021Short title
Sec. 8021Short title
Sec. 8021Short title
Sec. 8022Definitions
Sec. 8022Assisting States with implementation of plans of safe care
Sec. 8022Definitions
Sec. 8022Assisting States with implementation of plans of safe care
Sec. 8023Unfair or deceptive acts or practices with respect to substance use disorder treatment service and products
Sec. 8023Unfair or deceptive acts or practices with respect to substance use disorder treatment service and products
Sec. 8031Short title
Sec. 8031Short title
Sec. 8032Interagency Task Force to Improve the Federal Response to Families Impacted by Substance Use Disorders
Sec. 8032Interagency Task Force to Improve the Federal Response to Families Impacted by Substance Use Disorders
Sec. 8041Addressing economic and workforce impacts of the opioid crisis
Sec. 8041Establishment of an Advisory Committee on Opioids and the Workplace
Sec. 8041Addressing economic and workforce impacts of the opioid crisis
Sec. 8041Establishment of an Advisory Committee on Opioids and the Workplace
Sec. 8051Peer support counseling program for women veterans
Sec. 8051Short title
Sec. 8051Peer support counseling program for women veterans
Sec. 8051Short title
Sec. 8052Hiring by Department of Veterans Affairs of additional Veterans Justice Outreach Specialists
Sec. 8052Hiring by Department of Veterans Affairs of additional Veterans Justice Outreach Specialists
Sec. 8061Short title
Sec. 8061Peer support counseling program for women veterans
Sec. 8061Short title
Sec. 8061Peer support counseling program for women veterans
Sec. 8062Drug abuse mitigation initiative
Sec. 8062Drug abuse mitigation initiative
Sec. 8071Pilot program to help individuals in recovery from a substance use disorder become stably housed
Sec. 8071Short title
Sec. 8071Pilot program to help individuals in recovery from a substance use disorder become stably housed
Sec. 8071Short title
Sec. 8072Drug abuse mitigation initiative
Sec. 8072Drug abuse mitigation initiative
Sec. 8081Supporting family-focused residential treatment
Sec. 8081Short title
Sec. 8081Supporting family-focused residential treatment
Sec. 8081Short title
Sec. 8082Improving recovery and reunifying families
Sec. 8082Findings
Sec. 8082Improving recovery and reunifying families
Sec. 8082Findings
Sec. 8083Building capacity for family-focused residential treatment
Sec. 8083Advisory Council To Support Grandparents Raising Grandchildren
Sec. 8083Building capacity for family-focused residential treatment
Sec. 8083Advisory Council To Support Grandparents Raising Grandchildren
Sec. 8084Definitions
Sec. 8084Definitions
Sec. 8091Short title
Sec. 8091Short title
Sec. 8091Short title
Sec. 8091Short title
Sec. 8092Reauthorization of the comprehensive opioid abuse grant program
Sec. 8092Reauthorization of the comprehensive opioid abuse grant program
Sec. 8092Reauthorization of the comprehensive opioid abuse grant program
Sec. 8092Reauthorization of the comprehensive opioid abuse grant program
Sec. 8101Short title
Sec. 8101Short title
Sec. 8102Alcohol and controlled substance testing of mechanical employees
Sec. 8102Alcohol and controlled substance testing of mechanical employees
Sec. 8103Department of Transportation public drug and alcohol testing database
Sec. 8103Department of Transportation public drug and alcohol testing database
Sec. 8104GAO report on Department of Transportation’s collection and use of drug and alcohol testing data
Sec. 8104GAO report on Department of Transportation’s collection and use of drug and alcohol testing data
Sec. 8105Transportation Workplace Drug and Alcohol Testing Program; addition of fentanyl and other substances
Sec. 8105Transportation Workplace Drug and Alcohol Testing Program; addition of fentanyl and other substances
Sec. 8106Status reports on hair testing guidelines
Sec. 8106Status reports on hair testing guidelines
Sec. 8107Mandatory Guidelines for Federal Workplace Drug Testing Programs using Oral Fluid
Sec. 8107Mandatory Guidelines for Federal Workplace Drug Testing Programs using Oral Fluid
Sec. 8108Electronic recordkeeping
Sec. 8108Electronic recordkeeping
Sec. 8109Status reports on Commercial Driver's License Drug and Alcohol Clearinghouse
Sec. 8109Status reports on Commercial Driver's License Drug and Alcohol Clearinghouse
Sec. 8121Short title
Sec. 8121Short title
Sec. 8122Criminal penalties
Sec. 8122Criminal penalties
Sec. 8201Short title
Sec. 8201Short title
Sec. 8202Reauthorization of the Office of National Drug Control Policy
Sec. 8202Reauthorization of the Office of National Drug Control Policy
Sec. 8203Reauthorization of the Drug-Free Communities Program
Sec. 8203Reauthorization of the Drug-Free Communities Program
Sec. 8204Reauthorization of the National Community Anti-Drug Coalition Institute
Sec. 8204Reauthorization of the National Community Anti-Drug Coalition Institute
Sec. 8205Reauthorization of the High-Intensity Drug Trafficking Area Program
Sec. 8205Reauthorization of the High-Intensity Drug Trafficking Area Program
Sec. 8206Reauthorization of drug court program
Sec. 8206Reauthorization of drug court program
Sec. 8207Drug court training and technical assistance
Sec. 8207Drug court training and technical assistance
Sec. 8208Drug overdose response strategy
Sec. 8208Drug overdose response strategy
Sec. 8209Protecting law enforcement officers from accidental exposure
Sec. 8209Protecting law enforcement officers from accidental exposure
Sec. 8210COPS Anti-Meth Program
Sec. 8210COPS Anti-Meth Program
Sec. 8211COPS anti-heroin task force program
Sec. 8211COPS anti-heroin task force program
Sec. 8212Comprehensive Addiction and Recovery Act education and awareness
Sec. 8212Comprehensive Addiction and Recovery Act education and awareness
Sec. 8213Reimbursement of substance use disorder treatment professionals
Sec. 8213Reimbursement of substance use disorder treatment professionals
Sec. 8214Sobriety Treatment and Recovery Teams (START)
Sec. 8214Sobriety Treatment and Recovery Teams (START)
Sec. 8215Provider education
Sec. 8215Provider education
Sec. 8216Definitions
Sec. 8216Definitions
Sec. 8217Amendments to administration of the Office
Sec. 8217Amendments to administration of the Office
Sec. 8218Emerging threats committee, plan, and media campaign
Sec. 8218Emerging threats committee, plan, and media campaign
Sec. 8219Drug interdiction
Sec. 8219Drug interdiction
Sec. 8220GAO Audit
Sec. 8220GAO Audit
Sec. 8221National Drug Control Strategy
Sec. 8221National Drug Control Strategy
Sec. 8222Technical and conforming amendments to the Office of National Drug Control Policy Reauthorization Act of 1998
Sec. 8222Technical and conforming amendments to the Office of National Drug Control Policy Reauthorization Act of 1998
Sec. 8231Budgetary effect
Sec. 8231Budgetary effect
Sec. 9001Short title
Sec. 9001Short title
Sec. 9002Establishment of schedule A
Sec. 9002Establishment of schedule A
Sec. 9003Temporary and permanent scheduling of schedule A substances
Sec. 9003Temporary and permanent scheduling of schedule A substances
Sec. 9004Penalties
Sec. 9004Penalties
Sec. 9005False labeling of schedule A controlled substances
Sec. 9005False labeling of schedule A controlled substances
Sec. 9006Registration requirements for handlers of schedule A substances
Sec. 9006Registration requirements for handlers of schedule A substances
Sec. 9007Additional conforming amendments
Sec. 9007Additional conforming amendments
Sec. 9008Controlled substance analogues
Sec. 9008Controlled substance analogues
Sec. 9009Rules of construction
Sec. 9009Rules of construction
Sec. 9010Study by Comptroller General
Sec. 9010Study by Comptroller General
Sec. 9011Report on controlled substance analogues sold by means of the Internet
Sec. 9011Report on controlled substance analogues sold by means of the Internet
Sec. 9012Controlled substance analogues
Sec. 9012Controlled substance analogues
Sec. 10001Short title
Sec. 10001Short title
Sec. 10002Demonstration program to study the impact of using rental vouchers for supportive housing for individuals recovering from opioid use disorders or other substance use disorders
Sec. 10002Demonstration program to study the impact of using rental vouchers for supportive housing for individuals recovering from opioid use disorders or other substance use disorders
Sec. 10003Repeal of Rental Voucher Demonstration Program
Sec. 10003Repeal of Rental Voucher Demonstration Program
Sec. 10004Demonstration Close-Out
Sec. 10004Demonstration Close-Out
Sec. 10005No additional funds authorized
Sec. 10005No additional funds authorized
Sec. 11001Short title
Sec. 11001Short title
Sec. 11002Medicaid State plan option to provide services for certain individuals with targeted SUDs in institutions for mental diseases
Sec. 11002Medicaid State plan option to provide services for certain individuals with targeted SUDs in institutions for mental diseases
Sec. 11003Promoting value in Medicaid managed care
Sec. 11003Promoting value in Medicaid managed care